According to our latest study on “Intravascular Ultrasound (IVUS) Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type (Equipment and Accessories); Modality (Virtual Histology IVUS, iMap IVUS, and Integrated Backscatter IVUS); End User (Hospitals and Clinics, Diagnostic Centers, and Academic and Research Institutes),” the market is expected to grow from US$ 608.97 million in 2021 to US$ 1,012.37 million by 2028; it is estimated to grow at a CAGR of 7.5% from 2021 to 2028. The report highlights the key factors driving and restraining the market growth, trends prevailing in the market, and prominent players with their developments.
Intravascular ultrasound (IVUS) is a catheter-based diagnostic technique used to diagnose and treat both arteries and veins. Ultrasound does not use or produce any ionizing radiation, has no known harmful effects, and can provide clear images of soft tissues that are not well seen on x-ray images. IVUS shows the degree of narrowing or stenosis of an artery by providing a visual image of the inside of the artery (the lumen) and the atheroma hidden within the artery wall.
Get Sample Copy of this Report at https://www.theinsightpartners.com/sample/TIPRE00009788/
Based on type, the intravascular ultrasound (IVUS) devices market is bifurcated into equipment and accessories. The accessories segment held the largest share of the market in 2021 moreover, the same segment is anticipated to register the highest CAGR of 7.7% in the market during the forecast period. Equipment part of a devices is generally purchased once whereas accessories part of the devices is renewed time and again and are generally changed after they are used for a particular patient. According to the data provided by American Heart Association (AHA), in 2016, approximately 15.5 million persons in United States were suffering from coronary heart disease. The growing prevalence of cardiovascular disorders in different ages is the main reason for increase in demand for accessories segment. The rising R&D initiatives in the cardiovascular industry, improvement in the imaging and staining procedures, and the recent regulatory approvals are driving the growth of the market. The growth of market is widely driven by the presence of well-established and budding players across the globe
The report segments the intravascular ultrasound (IVUS) devices market as follows:
The intravascular ultrasound (IVUS) devices market is segmented based on type, modality, end user, and geography. Based on type, the market is segmented into equipment and accessories. Based on modality, the market is segmented into virtual histology IVUS, iMap IVUS, and integrated backscatter IVUS. Based on end user, the intravascular ultrasound (IVUS) devices market is segmented into hospitals and clinics, diagnostic centers, and academic and research institutes. Geographically, the intravascular ultrasound (IVUS) devices market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and Rest of Middle East & Africa), and South and Central America (Brazil, Argentina, and Rest of South and Central America).
Check Exclusive Discount on this Report at https://www.theinsightpartners.com/discount/TIPRE00009788/
The unprecedented impact of COVID-19 has been far-reaching, but the effects on cardiac patients make them one of the worst affected groups. COVID-19 has profoundly impacted the number of patients undergoing diagnosis, and treatment. The increased pressure due to the growing rate of COVID-19 patients’ hospitalization led to the re-profiling of many hospitals and departments, including cardiology clinics for treating patients with the COVID-19. The intravascular ultrasound (IVUS) devices market in Asia-Pacific is anticipated to grow at the fastest rate during the forecast period. China and India are major contributors to the market growth, owing to the increasing incidences of chronic diseases. According to the American College of Cardiology (ACC), around 40% of the COVID-19 recovered patients develop cardiovascular conditions.
Key Manufacturers Overview-
- Koninklijke Philips N.V.
- GE Healthcare
- Siemens AG
- Boston Scientific Corporation
- Infraredx, Inc.
- Terumo Corporation
- Axle International
- Conavi Medical Inc.
- Canon Medical Systems
- ACIST Medical System
Order a Copy of this Report at https://www.theinsightpartners.com/buy/TIPRE00009788/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi